Earnings call Dr. Lal PathLabs reported Q2 FY25 revenue of ₹660 crore, up 9.8% YoY, with PAT rising 18.1% to ₹131 crore. EBITDA margin expanded to 30.7%, supported by operating leverage and product ...

Jan 30 (Reuters) - India's Dr Lal Path Labs (DLPA.NS), opens new tab reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its ...

Dr. Lal Path Labs posts earnings dip on Indian labour code changes; test demand strong Dr. Lal Path Labs reported a lower third-quarter profit on Friday after taking a one-time charge linked to ...

Discover Dr Lal Path Labs diagnostic services in New Delhi, Delhi. Get directions and view its location on an interactive map. Search our database by state, city, or pincode to find information on ...

Stock market performance on Wednesday was fueled by the mixed reaction of investors who were cautious of US market uncertainties, declining oil prices, bond yields, and bullion. The stock market ended ...

(Reuters) -Dr Lal Path Labs, India's largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday as strong demand for its bundled test packages lifted growth amid ...

Discover Dr Lal Path Labs diagnostic services in Indore, Madhya Pradesh. Get directions and view its location on an interactive map. Search our database by state, city, or pincode to find information ...

Earnings call Dr. Lal PathLabs reported Q3 FY25 revenue of ₹597 crore, up 10.7% YoY, with EBITDA margin at 25.8% and PAT up 19.3% YoY. Growth was driven by volume gains, improved mix, and Swasthfit ...